KLRC2基因胚系突变介导乳腺癌抗HER2靶向治疗原发耐药分子机制研究
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | Optimized first-line therapy for stage IV breast cancer brings long-term disease-free survival: a case report and biological analysis | 期刊论文 | Li Bian;Fengrui Xu;Tao Wang;Huiqiang Zhang;Yang Cao;Zefei Jiang |
2 | Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy | 期刊论文 | Li B;Tao W;Shao-Hua Z;Ze-Rui Q;Fu-Quan J;Fan L;Ze-Fei J |
3 | Pyrotinib for metastatic breast cancer after multi-anti-HER2 targeted therapy: a case report | 期刊论文 | Feng Li;Li Bian;Zerui Qu;Jianbin Li;Fengrui Xu;Zefei Jiang |